Skip to main content
WeightCited

CLA 관련 Obesity

B

Cochrane meta-analysis of 18 RCTs (n=807) found CLA at 3.2 g/day reduced body fat mass by 1.33 kg over 6-12 months without significant change in body weight, suggesting lean mass preservation. A 2-year RCT (n=134) found sustained fat reduction. Effects are modest and require long-term use.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dcla\u0026condition\u003Dobesity'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  




    








    

        

            B

        

        

            
결론

            
            
Cochrane meta-analysis of 18 RCTs (n=807) found CLA at 3.2 g/day reduced body fat mass by 1.33 kg over 6-12 months without significant change in body weight, suggesting lean mass preservation. A 2-year RCT (n=134) found sustained fat reduction. Effects are modest and require long-term use.

            
            
        

    











    
    

        
        

            

  
Key Statistics





            


    

        
18

        
연구

    

    

        
807

        
참여자

    

    

        
            
            ↑
            
        
        
Positive

    

    

        B

        
등급

    




        


        
        

        
        
        

            

  
Dosage & Usage





            
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units


            
            

                
일반적으로 사용되는 용량

                

                    
                    

                        
general:

                        
3.2-6.4 g/day mixed isomers

                    

                    
                    

                        
bodycomposition:

                        
3.4 g/day (50:50 c9,t11:t10,c12 blend)

                    

                    
                    

                        
minimumeffective:

                        
3.2 g/day for ≥12 weeks

                    

                    
                

                
                

                    상한량: 6 g/day; higher doses may worsen insulin sensitivity
                

                
            

            

            

            
            

                권장 복용 시간: With meals; divide dose across 2-3 meals
            

            
        

        

        
        
        

            

  
Safety & Side Effects





            

                
                

                    
보고된 부작용

                    
    
                        
                        
  • 
                            ⚠
                            GI discomfort
                        
    • 
                        
                        
  • 
                            ⚠
                            May worsen insulin sensitivity at high doses
                        
    • 
                        
                        
  • 
                            ⚠
                            Possible HDL reduction
                        
    • 
                        
                        
  • 
                            ⚠
                            Fatty liver (in some rodent studies)
                        
    • 
                        
                    

                

                

                
                

                    
알려진 상호작용

                    
    
                        
                        
  • 
                            ●
                            Diabetes medications (may affect insulin sensitivity)
                        
    • 
                        
                        
  • 
                            ●
                            Blood thinners (theoretical)
                        
    • 
                        
                    

                

                

                
                

                    

                        일일 최대 섭취 허용량: 6 g/day; higher doses may worsen insulin sensitivity
                    

                

                
            

            

                건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
            

        

        

        
        
        

            

  
Frequently Asked Questions





            




    
    

        
            Does CLA help with Obesity?
            
        
        

            Based on 18 studies with 807 participants, there is moderate evidence from clinical studies that CLA may support Obesity management. Our evidence grade is B (Good Evidence).
        

    

    
    

        
            How much CLA should I take for Obesity?
            
        
        

            Studies have used various dosages. A commonly studied range is 3.2-6.4 g/day mixed isomers. Always consult your healthcare provider before starting any supplement regimen.
        

    

    
    

        
            Are there side effects of CLA?
            
        
        

            Reported side effects may include GI discomfort, May worsen insulin sensitivity at high doses, Possible HDL reduction, Fatty liver (in some rodent studies). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
        

    

    
    

        
            How strong is the evidence for CLA and Obesity?
            
        
        

            We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 807 total participants. The overall direction of effect is positive.
        

    

    




        

        

        
        
        

            

  
Related Evidence





            

                
                
                

                
            

        

        

    


    
    












    

        FDA 면책 조항:
        이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.